We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Read MoreHide Full Article
Albemarle (ALB - Free Report) closed at $64.95 in the latest trading session, marking a +1.88% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.52%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%.
Coming into today, shares of the specialty chemicals company had gained 10.89% in the past month. In that same time, the Basic Materials sector gained 4.06%, while the S&P 500 gained 5.95%.
Analysts and investors alike will be keeping a close eye on the performance of Albemarle in its upcoming earnings disclosure. The company's earnings report is set to go public on July 30, 2025. The company is predicted to post an EPS of -$0.76, indicating a 2000% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $1.21 billion, showing a 15.52% drop compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$1.67 per share and a revenue of $4.86 billion, representing changes of +28.63% and -9.54%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 8.44% downward. Right now, Albemarle possesses a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 222, this industry ranks in the bottom 10% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Exceeds Market Returns: Some Facts to Consider
Albemarle (ALB - Free Report) closed at $64.95 in the latest trading session, marking a +1.88% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.52%. Meanwhile, the Dow gained 1%, and the Nasdaq, a tech-heavy index, added 0.52%.
Coming into today, shares of the specialty chemicals company had gained 10.89% in the past month. In that same time, the Basic Materials sector gained 4.06%, while the S&P 500 gained 5.95%.
Analysts and investors alike will be keeping a close eye on the performance of Albemarle in its upcoming earnings disclosure. The company's earnings report is set to go public on July 30, 2025. The company is predicted to post an EPS of -$0.76, indicating a 2000% decline compared to the equivalent quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $1.21 billion, showing a 15.52% drop compared to the year-ago quarter.
For the entire fiscal year, the Zacks Consensus Estimates are projecting earnings of -$1.67 per share and a revenue of $4.86 billion, representing changes of +28.63% and -9.54%, respectively, from the prior year.
Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 8.44% downward. Right now, Albemarle possesses a Zacks Rank of #3 (Hold).
The Chemical - Diversified industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 222, this industry ranks in the bottom 10% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.